GlassScriptPhysician profile
Marc Berger
NPI 1598972325
$147,659.82
in general payments reported to CMS, 2019-2025
4 companies · $8,374 in 2025
The $8,374 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $25K · 2022: $79K · 2023: $1,400 · 2024: $34K · 2025: $8,374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $40K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,465 · Food and Beverage: $95.00 · Travel and Lodging: $85.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $40,145.35 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,465.00 |
| Food and Beverage | $95.00 |
| Travel and Lodging | $85.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan INC. | $92,062.35 | 2022-2025 | Tobi Podhaler, Dymista |
| Regeneron Pharmaceuticals, INC. | $26,278.47 | 2022-2025 | |
| Gilead Sciences, INC. | $25,000.00 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $4,319.00 | 2022-2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.